Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study.

Autor: Costa Clemens SA; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Institute of Global Health, University of Siena, Siena, Italy., Weckx L; Department of Pediatrics, Universidade Federal de São Paulo, São Paulo, Brazil., Clemens R; International Vaccine Institute, Seoul, Korea., Almeida Mendes AV; Escola Bahiana de Medicina e Saúde Pública, Salvador, Brazil; General Medicine, Hospital São Rafael, Salvador, Brazil; Instituto D'Or de Pesquisa e Ensino, Salvador, Brazil., Ramos Souza A; Universidade Federal de São Paulo, São Paulo, Brazil., Silveira MBV; Universidade Federal de São Paulo, São Paulo, Brazil., da Guarda SNF; General Medicine, Hospital São Rafael, Salvador, Brazil; Instituto D'Or de Pesquisa e Ensino, Salvador, Brazil; Department of Pediatrics, Universidade Federal da Bahia, Salvador, Brazil., de Nobrega MM; Universidade Federal de São Paulo, São Paulo, Brazil., de Moraes Pinto MI; Universidade Federal de São Paulo, São Paulo, Brazil., Gonzalez IGS; Universidade Federal de São Paulo, São Paulo, Brazil., Salvador N; Instituto D'Or de Pesquisa e Ensino, Salvador, Brazil., Franco MM; General Medicine, Hospital São Rafael, Salvador, Brazil; Instituto D'Or de Pesquisa e Ensino, Salvador, Brazil., de Avila Mendonça RN; General Medicine, Hospital São Rafael, Salvador, Brazil; Instituto D'Or de Pesquisa e Ensino, Salvador, Brazil., Queiroz Oliveira IS; General Medicine, Hospital São Rafael, Salvador, Brazil; Instituto D'Or de Pesquisa e Ensino, Salvador, Brazil., de Freitas Souza BS; Instituto D'Or de Pesquisa e Ensino, Salvador, Brazil; Gonçalo Moniz Institute, Fiocruz, Salvador, Brazil., Fraga M; Instituto D'Or de Pesquisa e Ensino, Salvador, Brazil., Aley P; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Bibi S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Cantrell L; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Dejnirattisai W; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Liu X; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Mongkolsapaya J; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Supasa P; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Screaton GR; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK; Chinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford, UK., Lambe T; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Chinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford, UK., Voysey M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK., Pollard AJ; NIHR Oxford Biomedical Research Centre, Oxford, UK. Electronic address: andrew.pollard@paediatrics.ox.ac.uk.

Publikováno v: Lancet (London, England) [Lancet] 2022 Feb 05; Vol. 399 (10324), pp. 521-529. Date of Electronic Publication: 2022 Jan 21.